Radnostix is recalling 2,699 units of its Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit because the Dibasic Sodium Phosphate capsules failed to meet quality specifications. The packs contain five empty capsules and five 300 mg Dibasic Sodium Phosphate capsules, which were distributed nationwide in the U.S. and Puerto Rico. Consumers who have these packs should check their lot numbers and expiration dates immediately. If you have been using this product, contact your healthcare provider or pharmacist for guidance.
The capsules failed to meet specific tablet or capsule manufacturing standards, which could potentially affect the safety or effectiveness of the medication during its intended use with the Sodium Iodide kit.
You have 2 options:
Quantity: 2,699 blister cartons
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.